name: Oral medication management - prior ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Injectable medication management - prior ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with ADL:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with IADL:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with medication administration:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with medical procedures &or treatments:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with management of equipment:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with supervision and safety:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with advocacy or facilitation of patient participation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Advocacy or facilitation of patient participation


name: ADL or IADL assistance frequency from any caregiver:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: ADL or IADL assistance frequency from any caregiver


name: Plan of care includes patient-specific parameters for notifying physician of changes:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Patient-specific parameters for notifying physician of changes


name: Plan of care includes diabetic foot care:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes fall prevention interventions:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes depression intervention:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes intervention to monitor and mitigate pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Intervention to monitor and mitigate pain


name: Plan of care includes intervention to prevent pressure injuries:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes pressure injury treatment - moist healing:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Emergent care utilized:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Reason for emergent care:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Deprecated Discharge disposition [CMS Assessment]


name: Reason for hospitalization:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Risk of developing pressure injuries:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Patient &or caregiver drug education intervention:Find:Pt:^Patient:Ord:OASIS-C


name: Management of injectable medications - ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Management of oral medications - ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Types and sources of assistance:-:RptPeriod:^Patient:-:CMS Assessment


name: Herpes simplex virus 2 Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Varicella zoster virus Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Beta hydroxybutyrate^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^5M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Lactate^1M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^3M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^5M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Albumin:MCnc:12H:Urine:Qn:Detection limit <= 20 mg/L


name: Cells.CD3+TCR alpha beta+/Cells:NFr:Pt:Body fld:Qn


name: Cells.CD3+TCR gamma delta+/Cells:NFr:Pt:Body fld:Qn


name: Liver kidney microsomal 1 Ab:Titr:Pt:Ser:SemiQn:IF


name: Muscle specific receptor tyrosine kinase Ab:ACnc:Pt:Ser:Qn:IA


name: Cells.terminal deoxyribonucleotidyl transferase:PrThr:Pt:Body fld:Ord


name: Toxoplasma gondii DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar


name: Deprecated Nuclear Ab [Titer] in Synovial fluid by Immunofluorescence


name: Nuclear Ab pattern:Imp:Pt:Synv fld:Nom:IF


name: Tubular basement membrane Ab:ACnc:Pt:Ser:Qn


name: Deprecated Soluble liver Ab [Presence] in Serum by Immunoassay


name: Chromosome 18 aneuploidy:Find:Pt:Amnio fld/CVS:Nom:FISH


name: Chromosome 13 aneuploidy:Find:Pt:Amnio fld/CVS:Nom:FISH


name: Deprecated Outcome and assessment information set (OASIS) form - version C - Death at home


name: Outcome and assessment information set (OASIS) form - version C - Death at home


name: Calcitriol^2H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcitriol^2H post dose calcium:MCnc:Pt:Ser/Plas:Qn


name: Calcitriol^3H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcitriol^3H post dose calcium:MCnc:Pt:Ser/Plas:Qn


name: Calcitriol^1H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcitriol^1H post dose calcium:MCnc:Pt:Ser/Plas:Qn


name: 11-Ketoandrosterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoandrosterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoandrosterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoandrosterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoandrosterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoandrosterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoetiocholanolone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoetiocholanolone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoetiocholanolone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Deoxycorticosterone^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1D post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1D post dose metyraPONE:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1D post dose metyraPONE:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post dose metyraPONE:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post dose metyraPONE:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^pre 250 ug corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^45M post 250 ug corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 11-Hydroxyandrosterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyandrosterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyandrosterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyandrosterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyandrosterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyandrosterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Ketogenic steroids^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Ketogenic steroids^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Hydroxypregnenolone^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^11th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^12th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1st specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^2nd specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^3rd specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^4th specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^5th specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^6th specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^7th specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 18-Hydroxycortisol^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 18-Hydroxycortisol^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycorticosterone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycorticosterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: Calcidiol^2H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcidiol^3H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcidiol^1H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^pre dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: Alpha cortolone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortolone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortolone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortolone^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortolone^pre dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortolone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortolone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: Androsterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Androsterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Other error requiring modification:Type:Pt:^Patient:Ord:MDSv3


name: Other error requiring modification.other specified:Type:Pt:^Patient:Nom:MDSv3


name: Other error requiring modification.other specified


name: Reasons for inactivation - event did not occur:Find:Pt:^Patient:Ord:MDSv3


name: Reasons for inactivation - event did not occur


name: Other error requiring error requiring inactivation:Find:Pt:^Patient:Ord:MDSv3


name: Other error requiring error requiring inactivation


name: Other error requiring error requiring inactivation.other specified:Find:Pt:^Patient:Nom:MDSv3


name: Other error requiring error requiring inactivation.other specified


name: Medicare non-therapy Part A HIPPS code:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Medicare non-therapy Part A - RUG version code:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Medicare non-therapy Part A - RUG version code


name: Alternate state Medicaid billing - RUG group:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Alternate state Medicaid billing - RUG version code:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Alternate state Medicaid billing - RUG version code


name: One or more unhealed pressure injuries stage 1 or higher:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Speech-language pathology and audiology services - individual minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Speech-language pathology and audiology services - individual minutes


name: Occupational therapy - individual minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Occupational therapy - individual minutes


name: Physical therapy - individual minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Participation in assessment:Find:RptPeriod:^Guardian or legally authorized representative:Nom:CMS Assessment


name: Items from most recent prior OBRA or scheduled PPS assessment:-:Pt:^Patient:-


name: Items from most recent prior OBRA or scheduled PPS assessment


name: Visual function - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Visual function - addressed in care plan


name: Visual function - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Infection of the foot:Find:Pt:^Patient:Ord:MDSv3


name: 3-Alpha-Androstanediol glucuronide^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^pre dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Androstanolone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Androstanolone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^post 25 mg captopril PO:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^pre 25 mg captopril PO:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^2H post 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^3H post 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^3H post 25 mg captopril PO:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^1H post 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^2H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^15M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^1H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^pre 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^pre dose dexamethasone:MRat:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortol^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortol^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortol^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortol^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortol^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortol^pre dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortol^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortol^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortolone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Newborn screening test results panel:-:Pt:Bld.dot:-


name: Progesterone^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Number of occult blood specimens recommended by testing kit protocol:Num:Pt:Stool:Qn


name: Number of occult blood specimens recommended by testing kit protocol


name: HEDIS 2010 Tests used in early prenatal care - ABO & Rh (PPC-C):-:Pt:^Patient:-


name: HEDIS 2010 Tests used in early prenatal care - ABO & Rh (PPC-C)


name: HEDIS 2010-2013 Tests used in early prenatal care - Rubella (PPC-C):-:Pt:^Patient:-


name: Androsterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Androsterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Androsterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Androsterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: C peptide^190M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^3.3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^1.3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Humidifier heated wire temperature differential setting:Temp:Pt:Ventilator airway circuit:Qn


name: Humidifier heated wire temperature differential setting


name: Tidal volume.spontaneous min setting:Vol:Pt:Ventilator.alarm:Qn


name: Tidal volume.inspired max setting:Vol:Pt:Ventilator.alarm:Qn


name: Tidal volume.exhaled max setting:Vol:Pt:Ventilator.alarm:Qn


name: Tubular basement membrane Ab:Titr:Pt:Ser:SemiQn:IF


name: U1 small nuclear ribonucleoprotein Ab:ACnc:Pt:Ser:Qn:IA


name: Protein fractions.oligoclonal bands.IgG:PrThr:Pt:Ser/Plas:Ord:Isoelectric focusing


name: Protein fractions.oligoclonal bands.IgM:PrThr:Pt:Ser/Plas:Ord:Isoelectric focusing


name: Coxiella burnetii Ab.IgM^2nd specimen:PrThr:Pt:Ser:Ord:IF


name: Legionella pneumophila Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IF


name: Legionella pneumophila Ab.IgG^2nd specimen:PrThr:Pt:Ser:Ord:IF


name: Mycoplasma pneumoniae Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IA


name: Mycoplasma pneumoniae Ab.IgG^2nd specimen:PrThr:Pt:Ser:Ord:IA


name: Chlamydia sp Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IA


name: Chlamydia sp Ab.IgG^2nd specimen:PrThr:Pt:Ser:Ord:IA


name: Coxiella burnetii Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IF


name: Coxiella burnetii Ab.IgG^2nd specimen:PrThr:Pt:Ser:Ord:IF


name: Lipid panel with direct LDL:-:Pt:Ser/Plas:Qn


name: Biotinidase deficiency newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Biotinidase deficiency newborn screening comment-discussion


name: Infant factors that affect newborn screening interpretation:Find:Pt:^Patient:Nom


name: Obstetric estimation of gestational age:Time:Pt:^Patient:Qn


name: State printed on filter paper card:ID:Pt:NBS card:Nom


name: Newborn screen card data panel:-:Pt:Bld.dot:-


name: Conditions tested for in this newborn screening study:ID:Pt:Bld.dot:Nom


name: Conditions tested for in this newborn screening study


name: Newborn conditions with equivocal markers:Prid:Pt:Bld.dot:Nom


name: Newborn conditions with equivocal markers


name: Unique bar code number:ID:Pt:Current sample:Nom


name: Newborn screening short narrative summary:Txt:Pt:^Patient:Nar


name: Newborn screening short narrative summary


name: Corticotropin^20M post XXX challenge:MCnc:Pt:Plas:Qn


name: Lactate^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^6M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Basement membrane zone BP180 Ab:ACnc:Pt:Ser:Qn:IA


name: IKBKG gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: TNFRSF13B gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: WAS gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Procollagen type III.N-terminal propeptide:ACnc:Pt:Ser:Qn


name: IKBKG gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: TNFRSF13B gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: WAS gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Coagulation factor XIII inhibitor:PrThr:Pt:PPP:Ord:Coag


name: Platelet factor 4 heparin complex induced Ab:PrThr:Pt:Ser/Plas:Ord:IA


name: Coagulation:TRto:Pt:PPP:Qn:Coag.surface induced.factor substitution.immediately after addition of normal plasma


name: Histoplasma capsulatum Ag:MCnc:Pt:Body fld:Qn


name: Trimipramine & Nortrimipramine panel:-:Pt:Ser/Plas:Qn


name: Campylobacter jejuni+Campylobacter coli Ag:PrThr:Pt:Stool:Ord


name: Salmonella typhi O Vi Ab:PrThr:Pt:Ser:Ord


name: Myeloperoxidase Ab & Proteinase 3 panel:-:Pt:Ser:Qn


name: Immunoglobulin light chains.free panel:-:Pt:Ser:Qn


name: Thyroglobulin & Thyroglobulin Ab panel:-:Pt:Ser/Plas:Qn


name: Thyroglobulin & Thyroglobulin Antibody panel


name: Complete blood count W Ordered Manual Differential panel:-:Pt:Bld:Qn


name: Complete blood count W Ordered Manual Differential panel


name: Dehydroepiandrosterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Dehydroepiandrosterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Dehydroepiandrosterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Dehydroepiandrosterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Dehydroepiandrosterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Dehydroepiandrosterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: Organic acidemia conditions suspected:Prid:Pt:Bld.dot:Nom


name: Fatty acid oxidation conditions suspected:Prid:Pt:Bld.dot:Nom


name: Fatty acid oxidation conditions suspected


name: Amino acidemia disorder suspected:Prid:Pt:Bld.dot:Nom


name: HEDIS 2010 Tests used in early prenatal care (PPC-C):-:Pt:^Patient:-


name: HEDIS 2010 Tests used in early prenatal care (PPC-C)


name: HEDIS 2010-2013 Codes to identify anticonvulsant serum concentration monitoring tests - carBAMazepine (MPM-E):-:Pt:^Patient:-


name: HEDIS 2010, 2011 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E):-:Pt:^Patient:-


name: HEDIS 2010, 2011 Codes to identify physiologic monitoring tests - Blood urea nitrogen (BUN) (MPM-A):-:Pt:^Patient:-


name: HEDIS 2010,2011 Codes to identify physiologic monitoring tests - Serum creatinine (SCr) (MPM-A):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify physiologic monitoring tests (MPM-A):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify physiologic monitoring tests (MPM-A)


name: HEDIS 2010 Codes to identify evidence of nephropathy (CDC-K):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify evidence of nephropathy (CDC-K)


name: HEDIS 2010 Codes to identify nephropathy screening tests (CDC-J):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify nephropathy screening tests (CDC-J)


name: HEDIS 2010 Codes to identify LDLc screening (CDC-H):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify LDLc screening (CDC-H)


name: HEDIS 2010 Codes to identify LDLc screening (CMC-D):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify LDLc screening (CMC-D)


name: HEDIS 2010-2013 Codes to identify Chlamydia screening (CHL-C):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify sexually active women (CHL-B):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify sexually active women (CHL-B)


name: HEDIS 2010 Codes to identify colorectal cancer screening (COL-A):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify colorectal cancer screening (COL-A)


name: Prescription for medical equipment or product:Find:Pt:{Setting}:Doc:{Role}


name: Prescription for medical equipment or product


name: Prescription for diagnostic or specialist care:Find:Pt:{Setting}:Doc:{Role}


name: Prescription for diagnostic or specialist care


name: Coagulation:Time:Pt:PPP:Qn:Dilute Russell viper venom induced.excess phospholipid


name: Activated clotting time:Time:Pt:PPP^Control:Qn:Coag.kaolin induced without excess phospholipids


name: Snowshoe hare virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Thyrotropin^5M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Cucumis melo cantalupensis basophil bound Ab:ACnc:Pt:Bld:Qn:LHR


name: Cucumis melo cantalupensis Ab.IgG4:MCnc:Pt:Ser:Qn


name: Cucumis melo cantalupensis Ab.IgG.RAST class


name: Cucumis melo spp Ab.IgG.RAST class:PrThr:Pt:Ser:Ord


name: Cucumis melo cantalupensis Ab.IgG:ACnc:Pt:Ser:Qn


name: Cucumis melo cantalupensis Ab.IgE.RAST class


name: Cucumis melo cantalupensis Ab.IgE:ACnc:Pt:Ser:Qn


name: Cucumis melo spp basophil bound Ab:ACnc:Pt:Bld:Qn:LHR


name: Pregnanediol^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Pregnanediol^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Pregnanediol^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Pregnanediol^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Pregnanediol^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Pregnanediol^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: C peptide^100M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Influenza virus A H1.neuraminidase inhibitor resistance:Susc:Pt:XXX:Ord:Genotyping


name: Influenza virus A H1.neuraminidase inhibitor resistance


name: Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance:Susc:Pt:XXX:Ord:Genotyping


name: Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance


name: Influenza virus A+B.neuraminidase inhibitor resistance:Susc:Pt:XXX:Ord:Genotyping


name: Influenza virus A+B.neuraminidase inhibitor resistance


name: Clostridioides difficile glutamate dehydrogenase:PrThr:Pt:Stool:Ord


name: C. difficile Glutamate Dehydrogenase Measurement


name: B little g super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: B little g super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: B little g super little a Ag:PrThr:Pt:RBC:Ord


name: AIRE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: ADNFLE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Basement membrane zone BP230 Ab:ACnc:Pt:Ser/Plas:Qn


name: Borrelia burgdorferi C6 Ab:PrThr:Pt:Ser:Ord


name: CACNA1S+SCN4A gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CDKN2A+CDK4 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CFTR+PRSS1+SPINK1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Coccidioides immitis Ab.IgG:PrThr:Pt:CSF:Ord:Comp fix


name: CPVT1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: DPYD2A gene targeted mutation analysis:Arb:Pt:Bld/Tiss:Ord:Molgen


name: FECH gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: FLCN gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Glucose^3H post 75 g glucose PO:MCnc:Pt:Urine:Qn


name: Glucose^4th specimen post dose lactose:MCnc:Pt:Ser/Plas:Qn


name: Glucose^5th specimen post dose lactose:MCnc:Pt:Ser/Plas:Qn


name: IDUA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Influenza virus A H2 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Insulin-like growth factor^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: KRIT1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Legionella pneumophila 1+3+4+5+6+8 Ab:PrThr:Pt:Ser:Ord


name: MSH2 gene+MLH1 gene+MSH6 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PKD2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: HLA-B SBT:Type:Pt:Bone mar:Nom:High resolution


name: RYR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: SCN4A gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Inpatient procedure relevant to plan of care:Type:Pt:^Patient:Nom:OASIS-C


name: Date pressure injury first identified:Date:RptPeriod:Pressure injury.oldest non-epithelialized stage 2:Qn:CMS Assessment


name: C little h super little a Ag:PrThr:Pt:RBC:Ord


name: C little h super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little o super little a Ag:PrThr:Pt:RBC:Ord


name: C little o super little b Ag:PrThr:Pt:RBC:Ord


name: C little s super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little s super little a Ag:PrThr:Pt:Ser/Plas:Ord


name: D little o super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: D little o super little b Ag:PrThr:Pt:RBC:Ord


name: G little o super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: I little n super little b Ag:PrThr:Pt:RBC:Ord


name: I little n super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: J little r super little a Ag:PrThr:Pt:RBC:Ord


name: J little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: K little n super little a Ag:PrThr:Pt:RBC:Ord


name: K little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: K little n super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: K little n super little b Ag:PrThr:Pt:RBC:Ord


name: M little c C super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: R little g super little a Ag:PrThr:Pt:RBC:Ord


name: R little g super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: W little r super little a Ag:PrThr:Pt:RBC:Ord


name: W little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: Y little k super little a Ag:PrThr:Pt:RBC:Ord


name: Y little k super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: Urinalysis complete W Reflex Culture panel:-:Pt:Urine:-


name: Urinalysis complete W Reflex Culture panel


name: Current number of unhealed (non-epithelialized) pressure injuries at each stage:-:Pt:^Patient:-:OASIS-C


name: When confused within the last 14D:Find:14D:^Patient:Ord:CMS Assessment


name: Current payment sources for home care.other specified:Find:Pt:^Patient:Nom:OASIS-C


name: Current payment sources for home care.other specified


name: Inpatient discharge facility.other specified:Type:Pt:^Patient:Nom:OASIS-C


name: Inpatient discharge facility.other specified


name: Swing bed clinical change assessment:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Entry &or discharge reporting:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Multidrug-resistant organism (MDRO) in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Multidrug-resistant organism (MDRO) in last 7D


name: Wound infection (other than foot) in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Wound infection (other than foot) in last 7D


name: Neurogenic bladder in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Obstructive uropathy in the last 7D:Find:7D:^Patient:Ord:MDSv3


name: Huntington's disease in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Tourette's syndrome in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Psychotic disorder (other than schizophrenia) in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Psychotic disorder (other than schizophrenia) in last 7D


name: Respiratory failure in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Staff pain assessment interview should be conducted:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Staff pain assessment interview should be conducted


name: Frequency of indicator of pain or possible pain:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Frequency of indicator of pain or possible pain


name: Unable to examine oral or dental status:Find:Pt:^Patient:Ord:MDSv3


name: Patient health questionnaire 2 item:-:2W:^Patient:-:PHQ.CMS


name: Prior Functioning ADL and IADL:-:RptPeriod:^Patient:-:CMS Assessment


name: Resident has one or more unhealed pressure injuries at stage 1 or higher:Find:Pt:^Patient:Ord:MDSv3


name: Resident has one or more unhealed pressure injuries at stage 1 or higher


name: Date of oldest stage 2 pressure injury:Date:RptPeriod:Pressure injury.oldest non-epithelialized stage 2:Qn:CMS Assessment


name: Other open lesion(s) on the foot:Find:Pt:^Patient:Ord:MDSv3


name: Number of D injection of any type were received in last 5D or since admission &or reentry if less than 7D:Num:7D:^Patient:Qn:MDSv3


name: Number of D injection of any type were received in last 5D or since admission &or reentry if less than 7D


name: Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D


name: Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D


name: Antibiotic received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Antibiotic received in last 7D or since admission &or reentry if less than 7D


name: Diuretic received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Diuretic received in last 7D or since admission &or reentry if less than 7D


name: Date of influenza vaccination:Date:Pt:^Patient:Qn


name: Speech-language pathology and audiology services:-:Pt:^Patient:-:MDSv3


name: Speech-language pathology and audiology services


name: Speech-language pathology and audiology services - concurrent minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Speech-language pathology and audiology services - concurrent minutes


name: Speech-language pathology and audiology services - group minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Speech-language pathology and audiology services - group minutes


name: Occupational therapy - concurrent minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Occupational therapy - concurrent minutes


name: Occupational therapy - group minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Physical therapy - concurrent minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Physical therapy - group minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Resident's overall goal established during assessment process:Find:Pt:^Patient:Nom:MDSv3


name: Resident's overall goal established during assessment process


name: Information source for overall goal:Find:Pt:^Patient:Nom:MDSv3


name: Active discharge planning in place for resident return to community:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Active discharge planning in place for resident return to community


name: Determination made by resident and core planning team regarding discharge to community:Find:Pt:^Patient:Nom:MDSv3


name: Determination made by resident and core planning team regarding discharge to community


name: Resident has been asked about returning to the community:Find:Pt:^Patient:Nom:MDSv3


name: Resident has been asked about returning to the community


name: Wants to talk to someone about the possibility of returning to the community:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Wants to talk to someone about the possibility of returning to the community


name: Referral has been made to the local contact agency:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Referral has been made to the local contact agency


name: Prior assessment brief interview for mental status summary score:Score:Pt:^Patient:Qn:MDSv3


name: Prior assessment brief interview for mental status summary score


name: Prior assessment resident mood interview (PHQ-9) total severity score:Score:Pt:^Patient:Qn:MDSv3


name: Prior assessment resident mood interview (PHQ-9) total severity score


name: Prior assessment staff assessment of resident mood interview (PHQ-9) total severity score:Score:Pt:^Patient:Qn:MDSv3


name: Prior assessment staff assessment of resident mood interview (PHQ-9) total severity score


name: Care Area Assessment (CAA) Summary:-:Pt:^Patient:-:MDSv3


name: Care Area Assessment (CAA) and care planning:-:Pt:^Patient:-:MDSv3


name: Care Area Assessment (CAA) and care planning


name: Care Area Assessment (CAA) results:-:Pt:^Patient:-:MDSv3


name: Delirium - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Delirium - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Cognitive loss &or dementia - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Cognitive loss &or dementia - care area triggered


name: Cognitive loss &or dementia - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Cognitive loss &or dementia - addressed in care plan


name: Communication - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Communication - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: ADL functional &or rehabilitation potential - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: ADL functional &or rehabilitation potential - care area triggered


name: ADL functional &or rehabilitation potential - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: ADL functional &or rehabilitation potential - addressed in care plan


name: Urinary incontinence and indwelling catheter - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Urinary incontinence and indwelling catheter - care area triggered


name: Urinary incontinence and indwelling catheter - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Urinary incontinence and indwelling catheter - addressed in care plan


name: Psychosocial well being - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Psychosocial well being - care area triggered


name: Psychosocial well being - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Psychosocial well being - addressed in care plan


name: Mood state - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Mood state - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Behavioral symptoms - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Behavioral symptoms - care area triggered


name: Behavioral symptoms - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Behavioral symptoms - addressed in care plan


name: Activities - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Activities - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Falls - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Falls - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Nutritional status - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Nutritional status - care area triggered


name: Nutritional status - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Nutritional status - addressed in care plan


name: Feeding tube - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Feeding tube - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Dehydration &or fluid maintenance - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Dehydration &or fluid maintenance - care area triggered


name: Dehydration &or fluid maintenance - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Dehydration &or fluid maintenance - addressed in care plan


name: Dental care - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Dental care - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Pressure injury - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Pressure injury - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Pressure injury - addressed in care plan


name: Psychotropic drug use - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Psychotropic drug use - care area triggered


name: Psychotropic drug use - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Psychotropic drug use - addressed in care plan


name: Physical restraints - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints - care area triggered


name: Physical restraints - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints - addressed in care plan


name: Pain - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Pain - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Return to community referral - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Return to community referral - care area triggered


name: Return to community referral - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Return to community referral - addressed in care plan


name: Date of Care Area Assessment (CAA) information:Date:Pt:^Patient:Qn:MDSv3


name: Date of Care Area Assessment (CAA) information


name: Location of Care Area Assessment (CAA) information:Find:Pt:^Patient:Ord:MDSv3


name: Location of Care Area Assessment (CAA) information


name: Type of record:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Saccharomyces cerevisiae Ab.IgG.RAST class


name: 10 minutes pre dose gonadotropin releasing hormone


name: 1st specimen post dose gonadotropin releasing hormone


name: 20 minutes post dose gonadotropin releasing hormone


name: 2nd specimen post dose gonadotropin releasing hormone


name: 3rd specimen post dose gonadotropin releasing hormone


name: 4th specimen post dose gonadotropin releasing hormone


name: 5th specimen post dose gonadotropin releasing hormone


name: 6th specimen post dose gonadotropin releasing hormone


name: 7th specimen post dose gonadotropin releasing hormone


name: immediately after 1:2 addition of platelet lysate


name: immediately after 1:2 addition of saline


name: Consensus Measures for Phenotypes and Exposures (PhenX)


name: Hemogram WO Platelets & W Manual Differential panel


name: Additional International classification of diseases diagnosis 1 in last 7D


name: Additional International classification of diseases diagnosis 10 in last 7D


name: Additional International classification of diseases diagnosis 2 in last 7D


name: Additional International classification of diseases diagnosis 3 in last 7D


name: Additional International classification of diseases diagnosis 4 in last 7D


name: Additional International classification of diseases diagnosis 5 in last 7D


name: Additional International classification of diseases diagnosis 6 in last 7D


name: Additional International classification of diseases diagnosis 7 in last 7D


name: Additional International classification of diseases diagnosis 8 in last 7D


name: Additional International classification of diseases diagnosis 9 in last 7D


name: Application of nonsurgical dressings (with or without topical medications) other than to feet provided in last 7D


name: Asthma &or chronic obstructive lung disease or chronic lung disease in last 7D


name: Atrial fibrillation and other dysrhythmias in last 7D


name: Body weight more or less than 5.5 pounds (2500 g)


name: Body weight more or less than 9.0 pounds (4100 g)


name: Cataracts &or glaucoma or macular degeneration in last 7D


name: Complete blood count WO Differential panel


name: Cerebrovascular accident &or transient ischemic attack &or stroke in last 7D


name: Circumference.at maximal protrusion of gluteus muscles


name: Deep venous thrombosis &or pulmonary embolus or pulmonary thrombo-embolism in last 7D


name: Depression other than bipolar in last 7D


name: MDS supplemental items section - version 2.0


name: MDS quarterly assessment form - version 2.0 - optional version for RUG-III


name: MDS quarterly assessment form - version 2.0 - optional version for RUG-III 1997 update


name: Fall one or more times in the last 2 to 6Mo prior to admission


name: Flunitrazepam & 7-Aminoflunitrazepam panel


name: Gastroesophageal reflux disease &or pressure injury in last 7D


name: HEDIS 2009, 2010 Codes to identify anticonvulsant serum concentration monitoring tests - Phenytoin (MPM-E)


name: HEDIS 2009, 2010 Codes to identify exclusions (CHL-D)


name: Horizontal adduction.active range of motion


name: Influenza virus A H1 2009 pandemic RNA panel


name: Influenza virus.neuraminidase inhibitor resistance


name: Limb prosthesis normally used in last 7D


name: How are you today: limited in what I can do


name: Manic depression other than schizophrenia in last 7D


name: MDS background information at admission form - version 2.0


name: MDS basic assessment tracking form - version 2.0


name: MDS quarterly assessment form - version 2.0


name: None of the above active diagnoses in last 7D


name: None of these signs of pain observed or documented in last 5D


name: Outcome and assessment information set (OASIS) form - version B1


name: Post-traumatic stress disorder in last 7D


name: Protective body movements or postures in last 5D


name: Protein or calorie malnutrition or at risk for malnutrition in last 7D


name: Renal insufficiency or renal failure &or end-stage renal disease in last 7D


name: Ulcerative colitis &or Crohn's disease &or inflammatory bowel disease in last 7D


name: Worsening in pressure injury status since last assessment (OBRA, PPS, or Discharge)


name: Avon Longitudinal Study of Parents and Children


name: Clinical.estimated from prior gest age assessment


name: Estimated from date fundal height reaches umb


name: National Council on Strenght and Fitness (NCFS)


name: Outcome and assessment information set (OASIS)-C


name: Saccharomyces cerevisiae leukotriene release


name: Confusion Assessment Method (CAM):-:Pt:^Patient:-:Observed.CAM.CARE


name: Inattention during 2D assessment period:Find:2D:^Patient:Ord:Observed.CAM.CARE


name: Disorganized thinking during 2D assessment period:Find:2D:^Patient:Ord:Observed.CAM.CARE


name: Altered level of consciousness &or alertness during 2D assessment period:Find:2D:^Patient:Ord:Observed.CAM.CARE


name: Psychomotor retardation during 2D assessment period:Find:2D:^Patient:Ord:Observed.CAM.CARE


name: Horizontal adduction.active range of motion:Angle:Pt:Shoulder.left:Qn


name: Body weight more or less than 5.5 pounds (2500 g)^at birth:Find:Pt:^Patient:Ord:Reported


name: Deprecated PhenX measure - child head circumference


name: Deprecated PhenX measure - hand dominance


name: Deprecated PhenX measure - hip circumference


name: Circumference.at maximal protrusion of gluteus muscles:Len:Pt:Pelvis:Qn


name: Deprecated PhenX measure - maximum adult height


name: Self-Reported Maximum Adult Height:-:Pt:^Patient:-


name: Body height^at age 25:Len:Pt:^Patient:Qn:Stated


name: Deprecated PhenX measure - maximum adult weight


name: Self-Reported Maximum Adult Weight:-:Pt:^Patient:-


name: Varicella zoster virus Ab.IgM^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Influenza virus A Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Influenza virus A Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Influenza virus A Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Influenza virus A Ab.IgM^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Influenza virus B Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Influenza virus B Ab.IgM^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Corticotropin^40M post XXX challenge:MCnc:Pt:Plas:Qn


name: Calcium.ionized^^adjusted to pH 7.4:MCnc:Pt:Ser/Plas:Qn:ISE


name: Deprecated Minimum Data Set - version 3.0


name: Federal OBRA reason for assessment:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Signs and symptoms of delirium (from CAM):-:Pt:^Patient:-:Observed.CAM.MDSv3


name: Inattention in last 7D:Find:7D:^Patient:Nom:CAM.CMS


name: Disorganized thinking in last 7D:Find:7D:^Patient:Ord:CAM.CMS


name: Altered level of consciousness in last 7D:Find:7D:^Patient:Ord:CAM.CMS


name: Psychomotor retardation in last 7D:Find:7D:^Patient:Ord:Observed.CAM.MDSv3


name: None of these signs of pain observed or documented in last 5D:Find:5D:^Patient:Ord:MDSv3


name: Fall one or more times in the last 2 to 6Mo prior to admission:Find:6Mo:^Patient:Ord:CMS Assessment


name: Guardian or legally authorized representative


name: Limb prosthesis normally used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Indwelling catheter used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: External catheter used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Anemia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Atrial fibrillation and other dysrhythmias in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Coronary artery disease in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Deep venous thrombosis &or pulmonary embolus or pulmonary thrombo-embolism in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Hypertension in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Peripheral Vascular Disease or Peripheral Arterial Disease:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Cirrhosis in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Gastroesophageal reflux disease &or pressure injury in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Ulcerative colitis &or Crohn's disease &or inflammatory bowel disease in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Benign prostatic hyperplasia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Renal insufficiency or renal failure &or end-stage renal disease in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Pneumonia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Septicemia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Tuberculosis in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Viral hepatitis in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Hyponatremia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Hyperkalemia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Hyperlipidemia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Thyroid disorder in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Arthritis in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Osteoporosis in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Hip fracture in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Other fracture in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Alzheimer's disease in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Aphasia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Cerebral palsy in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Cerebrovascular accident &or transient ischemic attack &or stroke in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Non-Alzheimer's dementia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Hemiplegia &or hemiparesis in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Paraplegia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Quadriplegia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Multiple sclerosis in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Parkinson's disease in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Seizure disorder or epilepsy:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Traumatic brain injury in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Protein or calorie malnutrition or at risk for malnutrition in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Anxiety disorder in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Depression other than bipolar in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Manic depression other than schizophrenia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Schizophrenia in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Post-traumatic stress disorder in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Asthma &or chronic obstructive lung disease or chronic lung disease in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Cataracts &or glaucoma or macular degeneration in last 7D:Find:7D:^Patient:Ord:MDSv3


name: None of the above active diagnoses in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Pain has made it hard to sleep:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Limited activities because of pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Rate pain severity using verbal descriptor scale:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-verbal sounds of pain in last 5D:Find:5D:^Patient:Ord:MDSv3


name: Vocal complaints of pain in last 5D:Find:5D:^Patient:Ord:MDSv3


name: Facial expressions of pain in last 5D:Find:5D:^Patient:Ord:MDSv3


name: Protective body movements or postures in last 5D:Find:5D:^Patient:Ord:MDSv3


name: Other disease diagnoses in last 7D:-:7D:^Patient:-:MDSv3


name: Application of nonsurgical dressings (with or without topical medications) other than to feet provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Thyrotropin^3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Latex recombinant (rHev b) 3 Ab.IgE:ACnc:Pt:Ser:Qn


name: Latex recombinant (rHev b) 5 Ab.IgE:ACnc:Pt:Ser:Qn


name: Latex recombinant (rHev b) 8 Ab.IgE:ACnc:Pt:Ser:Qn


name: Epstein Barr virus early Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Epstein Barr virus capsid Ab.IgM:ACnc:Pt:CSF:Qn:IA


name: 11-Deoxycorticosterone^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Toxoplasma gondii Ab.IgG avidity:Ratio:Pt:Ser:Qn:IA


name: Toxoplasma gondii Ab.IgG avidity:PrThr:Pt:Ser/Plas:Ord:IA


name: 17-Hydroxyprogesterone^1D post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^2D post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 18-Hydroxydeoxycorticosterone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 18-Hydroxydeoxycorticosterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Helianthus annuus seed Ab.IgG4:MCnc:Pt:Ser:Qn


name: Pregnancy weight gain.most recent:-:Pt:^Patient:-


name: Body weight more or less than 9.0 pounds (4100 g)^at birth:Find:Pt:^Patient:Ord:Reported


name: (Chicken feather+Duck feather+Goose feather+Turkey feather) Ab.IgG4:MCnc:Pt:Ser:Qn


name: Triticum aestivum pollen Ab.IgG4:MCnc:Pt:Ser:Qn


name: EGFR gene exon 19 deletion:Arb:Pt:Bld/Tiss:Ord:Molgen


name: Measurement of platelet antibody (procedure)


name: Monitoring of blood pressure, temperature, pulse rate and respiratory rate


name: BANDAGE,DERMACEA 2IN X 4YD NONSTERILE KEN#441124


name: BANDAGE,DERMACEA 2IN X 4YD STERILE KEN#441108


name: BANDAGE,DERMACEA 3IN X 4YD NONSTERILE KEN#441123


name: BANDAGE,DERMACEA 4IN X 4YD NONSTERILE KEN#441122


name: BANDAGE,DERMACEA 4IN X 4YD STERILE KEN#441105


name: BANDAGE,DERMACEA 6IN X 4YD NONSTERILE KEN#441121


name: BANDAGE,DERMACEA 6IN X 4YD STERILE KEN#441109


name: BELT,SUPPORT 5IN X-LARGE NU-HOPE #6323-B


name: BELT,SUPPORT 6IN X-LARGE NU-HOPE #6603-A


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6434-A


name: BELT,SUPPORT 7IN XX-LARGE NU-HOPE #6444-F


name: CATHETER,FOLEY 2-WAY 12FR 5CC BARD#265712


name: CATHETER,FOLEY 2-WAY 14FR 5CC BARD#265714


name: CATHETER,FOLEY 2-WAY 16FR 5CC BARD#265716


name: CATHETER,FOLEY 2-WAY 18FR 5CC BARD#265718


name: CATHETER,FOLEY 2-WAY 20FR 5CC BARD#265720


name: CATHETER,FOLEY 2-WAY 22FR 5CC BARD#265722


name: CATHETER,FOLEY 2-WAY 24FR 5CC BARD#265724


name: CATHETER,FOLEY 2-WAY 26FR 5CC BARD#265726


name: CATHETER,FOLEY 2-WAY 28FR 5CC BARD#265728


name: CATHETER,INTERMITTENT VINYL 10FR M#DYND10721


name: CATHETER,INTERMITTENT VINYL 12FR M#DYND10722


name: CATHETER,INTERMITTENT VINYL 14FR M#DYND10723


name: CATHETER,INTERMITTENT VINYL 16FR M#DYND10724


name: CATHETER,INTERMITTENT VINYL 18FR M#DYND10725


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 10FR COLOPLAST #1110


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 12FR COLOPLAST #1112


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 14FR COLOPLAST #1114


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 16FR COLOPLAST #1116


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 8FR COLOPLAST #1108


name: CATHETER,SELF-CATH 16FR COLOPLAST #50201


name: CATHETER,SELF-CATH COUDE 14FR COLOPLAST #50202


name: CATHETER,SELF-CATH COUDE 14FR COLOPLAST #50203


name: CATHETER,SELF-CATH COUDE 16FR COLOPLAST #50204


name: DRESSING,RESTORE CALCIUM ALGINATE AG 1IN X 12IN ROPE H#529969


name: DRESSING,RESTORE CALCIUM ALGINATE AG 2IN X 2IN H#529967


name: DRESSING,RESTORE CALCIUM ALGINATE AG 4IN X 4.75IN H#529968


name: {1 (45000 MG Benzoyl Peroxide 55 MG/ML Topical Cream [NeoBenz Micro]) / 7 (500 MG Benzoyl Peroxide 55 MG/ML Prefilled Applicator [NeoBenz Micro SD]) } Pack [NeoBenz Micro Cream Plus Pack]


name: Avobenzone/Homosalate/Octocrylene/Oxybenzone 3%-10%-3%-5% Topical application Lotion


name: {1 (180000 MG Benzoyl Peroxide 70 MG/ML Medicated Liquid Soap [NeoBenz Micro Wash]) / 7 (500 MG Benzoyl Peroxide 55 MG/ML Prefilled Applicator [NeoBenz Micro SD]) } Pack [NeoBenz Micro Wash Plus Pack]


name: Zinc Oxide;Cleanser;Lotion, Multi Ingredient;Oil, Multi Ingredient;Powder, Multi Ingredient;Shampoo, Multi Ingredient 10%; NA; NA; NA; NA; NA Multiple Routes Kit


name: Cream, Multi Ingredient Topical application Cream [Neosalus]


name: LifeShield Macrobore Extension Set, 0.2 micro


name: Wound Gel Dressing with Vitamin E & Aloe Vera


name: dihydrocodeine / phenylephrine / pyrilamine


name: Delflex Low Ca Low Mg with 1.5% Dextrose


name: Delflex Low Ca Low Mg with 2.5% Dextrose


name: {30 (ascorbic acid 120 MG / calcium citrate 125 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 20 MG / pyridoxine hydrochloride 25 MG Oral Tablet) / 10 (pyridoxine hydrochloride 25 MG Oral Tablet) } Pack [CitraNatal B-Calm Kit]


name: AccessPak for HIV PEP Expanded with Kaletra, oral kit


name: AccessPak for HIV PEP Expanded with Viracept, oral kit


name: blood pressure test kit medium and large cuffs MISCELL KIT


name: nutritional therapy for phenylketonuria(PKU) with iron no.27 10 gram-49 kcal/16.7 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for phenylketonuria(PKU) with iron no.27 60 gram-295 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy for phenylketonuria (PKU) with iron no.3 25 gram-374 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy for phenylketonuria (PKU) with iron no.3 25 gram-394 kcal/100 gram ORAL POWDER (GRAM)


name: syringe, disposable irrigation, 70 mL MISCELL SYRINGE (EA)


name: infant formula for PKU with iron combination no.4 13 gram-421 kcal/100 gram ORAL POWDER (GRAM)


name: iron polysaccharides complex, sodium feredetate


name: {5 (20 ML ifosfamide 50 MG/ML Injection) / 3 (mesna 100 MG/ML Injectable Solution) } Pack


name: Spray, Multi Ingredient Topical application Spray


name: generic drug products begining with the letter H


name: {1 (225 ML) (ammonium lactate 120 MG/ML Topical Lotion) / 1 (50 ML) (halobetasol propionate 0.0005 MG/MG Topical Ointment) } Pack


name: lamotrigine kit (For Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Rifampin and Not Taking Valproate) includes Green & Orange Pack


name: {4 (risedronate sodium 35 MG Oral Tablet) } Pack


name: Estimated date of delivery:Find:Pt:^Patient:Nar


name: Time contractions became regular:TmStp:Pt:^Patient:Qn


name: Deprecated Operative note - surgical drains (narrative)


name: Candida albicans Ab.IgA & IgG & IgM panel:-:Pt:Ser:Qn


name: brompheniramine maleate, pseudoephedrine hydrochloride drug combination


name: clindamycin phosphate benzoyl peroxide combination


name: green tea bioflavonoid, zinc ascorbate-containing toothpaste


name: pancreatic extract, povidone drug combination


name: aluminum hydroxide, dimethylpolsiloxane, magnesium carbonate, magesium hydroxide drug combination


name: aluminum hydroxide, benzocaine, magnesium hydroxide, sorbitol drug combination


name: aluminum hydroxide, magnesium hydroxide, sorbitol drug combination


name: aluminum hydroxide, benzocaine, magnesium hydroxide drug combination


name: aluminum glycinate, magnesium hydroxide, drug combination


name: Research Support, American Recovery and Reinvestment Act


name: Labor and Delivery record panel:-:Pt:^Patient:-


name: Croatian translation of the Medical Subject Headings


name: Transmyocardial Laser Revascularization (procedure)


name: Encounter due to acquired absence of larynx


name: Encounter due to twin liveborn infant, born in hospital


name: Encounter due to twin liveborn infant, born outside hospital


name: New Image Closed Pouch, Beige 1-3/4 inches


name: New Image Closed Pouch, Beige 2-1/4 inches


name: New Image Closed Pouch, Beige 2-3/4 inches


name: New Image Cut-to-Fit Convex Flextend with tap


name: Avobenzone/Octinoxate/Octisalate 3%-7.425%-2% Topical application Lotion


name: Meradimate/Octinoxate/Titanium Dioxide Topical application Lotion


name: MEBROFENIN 45 mg in 10 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION


name: CATHETER,EXTERNAL GOLDEN DRAIN MED #A2000M


name: CATHETER,FOLEY 2-WAY 14FR 10CC ROCHESTER #19214


name: CATHETER,FOLEY 2-WAY 14FR 10CC ROCHESTER #82514


name: CATHETER,FOLEY 2-WAY 16FR 10CC ROCHESTER #19216


name: CATHETER,FOLEY 2-WAY 16FR 10CC ROCHESTER #82516


name: CATHETER,FOLEY 2-WAY 18FR 10CC ROCHESTER #82518


name: CATHETER,FOLEY 2-WAY 20FR 10CC ROCHESTER #19220


name: CATHETER,FOLEY 2-WAY 20FR 10CC ROCHESTER #82520


name: CATHETER,FOLEY 2-WAY 22FR 10CC ROCHESTER #19222


name: CATHETER,FOLEY 2-WAY 22FR 10CC ROCHESTER #82522


name: CATHETER,FOLEY 2-WAY 24FR 10CC ROCHESTER #19224


name: CATHETER,FOLEY 2-WAY 24FR 10CC ROCHESTER #82524


name: CATHETER,FOLEY SILICONE 2-WAY 12FR 5CC KENDALL #3125


name: GLOVE LATEX SMALL CHEMO 18 MIL KEN#CT1091-1 (PAIR)


name: GLOVE LATEX MEDIUM CHEMO 18 MIL KEN#CT1092-1 (PAIR)


name: CATHETER,INTERMITTENT,MAGIC3 FEMALE 14FR ROCHESTER #51314


name: CATHETER,INTERMITTENT,MAGIC3 FEMALE 12FR ROCHESTER #51312


name: CATHETER,INTERMITTENT,MAGIC3 16FR ROCHESTER #53316


name: CATHETER,INTERMITTENT,MAGIC3 14FR ROCHESTER #53314


name: CATHETER,INTERMITTENT,MAGIC3 12FR ROCHESTER #53312


name: CATHETER,FOLEY SILICONE 2-WAY 30FR 5CC KENDALL #3577


name: CATHETER,FOLEY SILICONE 2-WAY 26FR 5CC KENDALL #3573


name: CATHETER,FOLEY 2-WAY 18FR 10CC ROCHESTER #19218


name: CATHETER,FOLEY SILICONE 2-WAY 14FR 30CC KENDALL #4149


name: CATHETER,FOLEY SILICONE 2-WAY 14FR 5CC KENDALL #3558


name: CATHETER,FOLEY SILICONE 2-WAY 16FR 30CC KENDALL #3601


name: CATHETER,FOLEY SILICONE 2-WAY 16FR 5CC KENDALL #3560


name: CATHETER,FOLEY SILICONE 2-WAY 18FR 30CC KENDALL #0187


name: CATHETER,FOLEY SILICONE 2-WAY 18FR 30CC KENDALL #3607


name: CATHETER,FOLEY SILICONE 2-WAY 18FR 5CC KENDALL #3563


name: CATHETER,FOLEY SILICONE 2-WAY 20FR 30CC KENDALL #0203


name: CATHETER,FOLEY SILICONE 2-WAY 20FR 30CC KENDALL #3611


name: CATHETER,FOLEY SILICONE 2-WAY 20FR 5CC KENDALL #3565


name: CATHETER,FOLEY SILICONE 2-WAY 22FR 30CC KENDALL #0229


name: CATHETER,FOLEY SILICONE 2-WAY 22FR 30CC KENDALL #3614


name: CATHETER,FOLEY SILICONE 2-WAY 22FR 5CC KENDALL #3567


name: CATHETER,FOLEY SILICONE 2-WAY 26FR 30CC KENDALL #3619


name: CATHETER,FOLEY SILICONE 2-WAY 28FR 30CC KENDALL #3623


name: CATHETER,FOLEY SILICONE 2-WAY 28FR 5CC KENDALL #3575


name: CATHETER,FOLEY SILICONE 2-WAY 30FR 30CC KENDALL #3631


name: GLOVE LATEX LARGE CHEMO 18 MIL KEN#CT1093-1 (PAIR)


name: VALVE PORT POSITIVE BOLUS NEEDLE FREE ALARIS #3000E


name: CATHETER,FOLEY SILICONE 2-WAY 24FR 30CC KENDALL #3618


name: CATHETER,FOLEY SILICONE 2-WAY 24FR 5CC KENDALL #3570


name: CATHETER,FOLEY SILICONE 2-WAY 26FR 30CC KENDALL #0260


name: medium chain triglycerides 7.7 kcal/mL ORAL OIL (ML)


name: Fora D15g Blood Glucose Monitor Plus Blood Pressure System


name: nut.tx.impaired digest fxn/fiber 16 gram-478 kcal/100 gram ORAL POWDER (GRAM)


name: nut.tx., phenylketonuria (PKU) with iron, no.41


name: nutritional therapy for impaired digestive function 16 gram-451 kcal/100 gram ORAL POWDER (GRAM)


name: Paradigm Sure-T Infusion Set 29G-6MM-32 inch


name: sodium dichloroacetate 100 % MISCELL POWDER (GRAM)


name: Methicillin-resistant Staphylococcus aureus test positive


name: Methicillin-resistant Staphylococcus aureus test negative


name: Methicillin-resistant Staphylococcus aureus test


name: Group B beta haemolytic Streptococcus positive


name: Group B beta haemolytic Streptococcus negative


name: Group B beta haemolytic Streptococcus test


name: Group A beta haemolytic Streptococcus positive


name: Eastern Cooperative Oncology Group performance status improved


name: Administration of Influenza A virus subtype H1N1 antigen only vaccine product


name: Neurological complication associated with device


name: Device specification incorrect for patient


name: Product contamination with blood derivative


name: Burkholderia cepacia complex test positive


name: Alpha glutathione s-transferase increased


name: Alpha glutathione s-transferase decreased


name: Alpha glutathione s-transferase abnormal


name: Urinary alpha glutathione s-transferase increased


name: Urinary alpha glutathione s-transferase decreased


name: Urinary alpha glutathione s-transferase abnormal


name: Urinary pi glutathione s-transferase increased


name: Urinary pi glutathione s-transferase decreased


name: Urinary pi glutathione s-transferase abnormal


name: Stenotrophomonas maltophilia test positive


name: Corynebacterium diphtheriae test positive


name: Antibiotic resistant enterococcus test positive


name: Corynebacterium minutissimum test positive


name: Antibiotic resistant Staphylococcus test positive


name: Alpha haemolytic Streptococcus test positive


name: Beta haemolytic Streptococcus test positive


name: Non-haemolytic Streptococcus test positive


name: Streptococcus viridans group test positive


name: Staphylococcus epidermidis test positive


name: Staphylococcus saprophyticus test positive


name: Streptobacillus moniliformis test positive


name: Raoultella ornithinolytica test positive


name: Shiga toxin-producing Escherichia coli test positive


name: Klebsiella ornithinolytica test positive


name: Haemophilus parainfluenzae test positive


name: Yersinia pseudotuberculosis test positive


name: Influenza A virus subtype H1N1 test positive


name: Influenza A virus subtype H5N1 test positive


name: Molluscum contagiosum virus test positive


name: Tick-borne encephalitis virus test positive


name: Human immunodeficiency virus test positive


name: Human immunodeficiency virus 1 test positive


name: Human immunodeficiency virus 2 test positive


name: Antibiotic resistant Staphylococcus test


name: Antibiotic resistant Staphylococcus test negative


name: Mycobacterium tuberculosis complex test positive


name: Mycobacterium tuberculosis test positive


name: Mycobacterium avium complex test positive


name: Human parainfluenza virus 1 test positive


name: Human parainfluenza virus 3 test positive


name: Foot-and-mouth disease virus test positive


name: Human T-lymphotropic virus 1 test positive


name: Human T-lymphotropic virus 2 test positive


name: Human respiratory syncytial virus test positive


name: Human T-lymphotropic virus test positive


name: Human parainfluenza virus 2 test positive


name: Human parainfluenza virus 4 test positive


name: Cerebrospinal fluid therapeutic procedures


name: Complication associated with vascular device


name: Device physical property and chemical issues


name: LYMPHOBLASTIC LEUKEMIA, ACUTE, SUSCEPTIBILITY TO


name: Dystonia, trunk and limbs (upper and lower)


name: White matter signal abnormalities in the deep white matter and periventricular regions


name: Iris strands attached to Schwalbe line bridging the iridocorneal angle


name: WAARDENBURG SYNDROME, TYPE 2E, WITH NEUROLOGIC INVOLVEMENT


name: Metaphyseal changes, mild, of knees and hips


name: Elevated androstenedione and testosterone


name: Dehydroepiandrosterone (DHEA) at upper level of normal range


name: DHEA sulfotransferase below limit of detection


name: Folliculitis of the scalp, trunk, and extensor surfaces of the extremities


name: Defective neutrophil adhesion to endothelial cells


name: Defective platelet adhesion with normal platelet count


name: Prominence and protrusion of upper third of the ear


name: Absence of the helix and distal scapha in middle third of the ear


name: Disjunction of otherwise normal lobule from remainder of ear


name: Shallow skin dimple on posterior surface of ear


name: POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1


name: Impaired seroconversion of immunoglobulins in response to vaccination


name: Some patients do not achieve ability to walk


name: Feeding difficulties due to facial obstruction and hypoglossia


name: Hypoglossia (absence of the anterior two-thirds of the tongue)


name: Deficiency of creatine phosphate in brain


name: Accumulation of guanidinoacetate in brain


name: Guanidinoacetate methyltransferase (GAMT) deficiency


name: Severe contractions of the facial muscles


name: Proximal megaepiphysis of metatarsal bones


name: Hypertrophy of branches of the hepatic artery


name: Sepiapterin reductase deficiency (fibroblasts)


name: Decreased urinary HVA, 5-HIAA, and vanillyl mandelic acid (VMA)


name: Transient hyperphenylalaninemia occurs on oral loading test with phenylalanine


name: Impaired coagulation due to malnutrition


name: EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 8


name: Widened proximal metaphyses of the femur and tibia


name: Hearing loss, sensorineural, postlingual progressive, moderate to severe


name: Impaired gait, some patients are never able to run


name: Red-green color defect in many patients with deletion downstream of exon 30


name: Deficiency of phosphatidylinositol (4,5) bisphosphate 5-phosphatase (PtdIns(4,5)P(2) 5-phosphatase) in cultured fibroblasts


name: Few mature neutrophils in the bone marrow


name: Skeletal muscle biopsy shows minor variation in fiber size


name: Disruption of sarcomeres with disorganization of the Z band


name: Decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma


name: Polymicrogyria, predominantly frontal and perisylvian


name: Constricted visual fields (occurs second)


name: Atrophy around the optic disc (in carrier females)


name: Irregular pigmentation of fundus (in carrier females)


name: Pain and paresthesia in the extremities, episodic


name: Vacuolization of glomerular and tubular epithelial cells


name: Whorl-like corneal dystrophy in carrier females


name: Intracellular glycosphingolipid deposition in all tissues of the body


name: Increased plasma globotriaosylsphingosine (lyso-GB3)


name: Mental retardation, borderline to severe


name: Continuous spike-wave discharges during sleep


name: Soft tissue growths at angle of mouth (female)


name: Absent/hypoplastic frontal sinuses (female)


name: Cortical thickening of long bones (female)


name: Excessive number of fingerprint arches (female)


name: Cortical thickening of metacarpals (female)


name: Leukodystrophy and white matter changes, which improve with age


name: Subcortical band or laminar heterotopia (in female carriers)


name: Abnormal argyrophilic neurons in the myenteric and submucosal plexuses


name: No mechanical intestinal obstructive lesion


name: Early onset skin cancer (basal cell, squamous cell and malignant melanoma)


name: Early freckle-like lesions in exposed areas


name: Absent root sheath components in bulb portion of plucked hair


name: Mental retardation (if untreated in infancy)


name: Rapid high RAI (radioactive iodine) uptake and turnover


name: Thyroid nodules, hyperplastic and adenomatous


name: Decreased or absent dihydropyrimidine dehydrogenase activity


name: Premature delivery, less than 37 weeks' gestation


name: Fibrin-rich alveolar deposits, 'hyaline membranes'


name: Increased CSF protein with normal cell count


name: Increased phytanic acid in body tissues and fluids


name: Decreased phytanic acid oxidase activity


name: Decreased or absent immunostaining for surfactant protein B


name: Increased immunostaining for surfactant proteins A and pro-C


name: Bronchopulmonary dysplasia may develop later


name: Delayed motor development, mild, transient


name: Increased urinary 7-biopterin (primapterin)


name: Paralysis, episodic, after strenuous exercise


name: Radiograph shows bilateral diffuse interstitial infiltrates


name: Radiograph shows ground glass appearance


name: Lung biopsy shows interstitial lymphoplasmocytic inflammation


name: Plump, hyperchromatic alveolar-lining cells or type II pneumocytes


name: Diffuse filling of alveoli with pigmented macrophages


name: Variable interstitial fibrosis may be present


name: Preservation of normal parenchymal architecture


name: Low or absent adrenocorticotropic hormone (ACTH)


name: Low or absent follicle stimulating hormone (FSH)


name: Phosphorylase kinase deficiency in liver and muscle


name: Glycogen accumulation in both liver and muscle


name: Muscle biopsy shows PAS-positive glycogen-containing vacuoles


name: Decreased homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) in CSF


name: Decreased or absent dihydropteridine reductase activity


name: Diffuse deposition of calcium oxalate in various tissues


name: Neuronal loss, particularly of cerebellar Purkinje cells


name: Limited mouth opening due to jaw contractures


name: Limited neck motion due to spinal contractures


name: Muscle weakness, mild, proximal and distal


name: Muscles have a woody consistency on palpation


name: Muscle biopsy shows fibrosis and increased connective tissue


name: Severe contractures of all joints, proximal and distal


name: Extraneuronal accumulation of autofluorescent pigmented material in various brain regions


name: Vacuolization in distal and collecting tubules


name: Disorganization of the neuromuscular junction


name: Amyloid deposition in muscle fibers occurs rarely


name: No evidence of intrauterine infection in mother or newborn


name: Absence of Lutheran antigen on red blood cells


name: Neurologic deficits may occur secondarily to malabsorption


name: Jejunal endoscopy shows white epithelium


name: Small bowel enterocytes accumulate lipid droplets in membrane-bound compartments or in the cytoplasm


name: Absence of chylomicrons in lymph and plasma


name: Matrix degeneration with large aggregated collagen fibers


name: Delayed closing of the ductus arteriosus


name: Increased neurologic sequelae of infections


name: Increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections


name: Impaired T cell proliferation and activation


name: Some patients may have autoantibodies to factor H, resulting in functional factor H deficiency


name: Decreased neopterin and biopterin in urine


name: Decreased neopterin and biopterin in CSF


name: Increased susceptibility to pneumocystis and cytomegalovirus infections


name: Increased urinary formiminoglutamic acid (FIGLU)


name: Hypoglycosylation of red blood cell membranes


name: Liver fibrosis with nodular regeneration, cholestasis, ductular proliferation, and iron deposition


name: Low or absent adrenocorticotropic hormone (ACTH) in some patients


name: Abnormal distribution of subcutaneous fat


name: Abnormal, broken, shortened elastic fibers


name: Prominent superficial blood vessels due to thin skin


name: Intellectual function may be high in milder cases


name: Encephalopathy associated with hypoglycemia


name: Delay in gross motor development due to weakness


name: Decreased carnitine in serum, muscle, heart, and liver


name: Impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes


name: Hypoketotic hypoglycemic episodes, acute


name: Rod-cone dystrophy, onset by end of 2nd decade (major)


name: Bile duct abnormalities (paucity, proliferation)


name: Arterial tortuosity (large and medium-sized arteries including aorta)


name: Elongated arteries (large and medium-sized arteries including aorta)


name: Arterial vessels show fragmentation of the internal elastic membrane


name: Arterial vessels show disruption of the elastic fibers of the tunica media


name: Anemia (not responsive to pyridoxine supplementation)


name: Ringed sideroblasts on bone marrow aspirate


name: Nerve biopsy showed demyelination, remyelination, and deposition of fat droplets in axons


name: Facial diplegia due to peripheral neuropathy


name: Decreased corneal sensation due to peripheral neuropathy


name: Accumulation of cholesterol esters in various tissues


name: Deficient efflux of intracellular cholesterol


name: Red reflex on transillumination of the iris


name: Bright copper-red coloration of skin (in darker-skinned individuals)


name: Mild hypopigmentation (in light-skinned individuals)


name: Bright copper-red hair (in darker-skinned individuals)


name: Stinging, burning vaginal pain during or after coitus


name: Positive skin test reaction to seminal fluid


name: Thick fibromuscular disc on stomach antrum


name: Hyperkeratosis, particularly on palms and soles of feet


name: Dark pigmentation of knees and dorsum of hands and feet


name: Ataxia, episodic (episodes last from hours to days)


name: Normal interictal neurologic examination


name: Cilia show nonflexible and hyperkinetic beating of axonemes


name: Recurrent respiratory infections due to impaired ciliary motility


name: Absence or hypoplasia of the anterior limb of the internal capsule


name: Hypoplasia or agenesis of the semicircular canals


name: Noonan-like facies in a minority of patients


name: EEG shows generalized polyspike and wave discharges (4-5 Hz)


name: EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5


name: Loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas


name: Skin biopsy shows noncaseating granulomas


name: Radiographic studies show a single ossification center in the sternum


name: Cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1


name: HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3


name: Alveoli filled with granular or foamy surfactant protein exudate


name: Alveoli contain desquamated type II pneumocytes and macrophages


name: Type II pneumocytes contain abnormal lamellar bodies


name: Radiograph shows granular, hazy, ground-glass interstitial opacifications


name: Cellular nonspecific interstitial pneumonitis


name: Areas of fibrosis may develop with longer disease duration


name: Radiography shows hazy, ground-glass interstitial opacifications


name: Decreased or absent mature surfactant C protein


name: Intraalveolar accumulation of abnormal pro-SPC protein


name: Serum IgG autoantibodies to granulocyte/macrophage colony-stimulating factor (GM-CSF, CSF2, 138960)


name: Opportunistic infections include Nocardia asteroides and Mycobacterium avium complex


name: Alveoli accumulate PAS-positive eosinophilic lipoproteinaceous material


name: Radiology shows bilateral airspace disease with ill-defined nodular or confluent pattern with perihilar predominance


name: CT scan shows patchy, ground-glass opacifications with superimposed interlobular septal and intralobular thickening leading to 'crazy paving' pattern


name: Pulmonary function tests show restrictive ventilatory defect


name: Ventilation-perfusion inequality with intrapulmonary shunting and widened alveolar-arteriolar diffusion gradient


name: Bronchoalveolar lavage fluid contains large, foamy macrophages


name: Recurrent infections due to ciliary dysfunction


name: Recurrent respiratory infections due to ciliary dysfunction


name: Increased risk of myelodysplastic syndromes


name: Muscle wasting due to chronic denervation


name: Brachydactyly (more severe than in hands)


name: Duplication of bases of second metatarsals


name: Conduction disease, sinoatrial and atrioventricular, progressive


name: Ventricular tachyarrhythmia (can result in sudden death)


name: Pulmonary hypertension, severe (in end-stage disease)


name: Abdominal distention due to mass effect of liver


name: Absence of teeth, variable (primarily the first and second premolars)


name: Microdeletion of chromosome 11q13 (43-490kb)


name: Vision loss, severe, beginning in childhood


name: Segmented neutrophils or band cells greater than 70%


name: Elicited repetitive daily blindness (ERDB)


name: Transient blindness (elicited by light, sudden standing, or direct pressure on the eyelid) lasting 3 to 10 seconds


name: Absent pupillary reflexes during blindness episodes


name: Normal retinal and pupillary reflexes between episodes


name: HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF


name: Tsc2 Angiomyolipomas, Renal, Modifier Of


name: Allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma


name: FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3


name: Distress and functional impairment resulting from hair pulling behavior


name: Alopecia resulting from compulsive hair pulling


name: Patients with factor XIII alpha subunit deficiency usually also have decreased levels of plasma factor XIII beta subunit


name: Muscle weakness usually following neuropathy


name: Muscle atrophy usually following neuropathy


name: Mean sleep latency is less than 5 to 8 minutes


name: Loss of hypocretin (orexin)-secreting neurons in the hypothalamus


name: Muscle biopsy shows enlargement of type I muscle fibers, consistent with denervation


name: Associated with autoimmune disorders (systemic lupus erythematosus 152700 and Hashimoto thyroiditis 140300)


name: Shortening of flexor profundus muscle-tendon unit


name: Shortening of various muscle-tendon groups in legs


name: Shortening of various muscle-tendon groups in feet


name: Alobar HPE shows absence of interhemispheric cleavage and single ventricle


name: Semilobar HPE shows posterior interhemispheric fissure with rudimentary cerebral hemispheres and single ventricle


name: Lobar HPE shows clear interhemispheric fissure and 2 lateral ventricles


name: Varying degrees of doubling of intrinsic ocular structures


name: LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR, LQ VARIANT


name: Short stature (final adult height less than 152cm)


name: Hypoplasia of the bones of the upper limbs and wrists


name: KRT16, 23-BP DEL, NT1244 AND 1-BP DEL, 1270G


name: Intrahepatic cholestasis during pregnancy, resolves postpartum


name: Increased serum bile acid concentration during pregnancy, resolves postpartum


name: Pruritus during pregnancy, resolves postpartum


name: Interpedicular distance widened at L1 on anteroposterior projection


name: Short and cleft vertebral bodies on lateral projection


name: Paresis of extensor muscles of the big toe is often the presenting symptom


name: Neurophysiologic studies show a predominantly motor neuropathy


name: Congenital cardiac malformations, variable


name: External capsule and claustrum may be involved


name: Usually precipitated by viral infection (influenza A, influenza B, parainfluenza II, and Mycoplasma pneumoniae)


name: FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2


name: Electrolyte disturbances from intractable diarrhea


name: No lamina propria mononuclear cell infiltration


name: Dependent on total parenteral nutrition (TPN)


name: XPC, 3-BP INS, GGT, CODON 580 AND LYS822GLN


name: Hypoplastic brainstem with loss of demarcation at the pontomedullary junction


name: Neuropathology shows alpha-synuclein-containing cytoplasmic inclusions in glial cells


name: Neurodegeneration in the substantia nigra


name: Increased sodium-potassium pump activity


name: EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8


name: EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 2


name: Lissencephaly (anterior to posterior increasing gradient of severity and more prominent in posterior brain regions)


name: Increased RAI (radioactive iodine) uptake


name: Increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (CSF)


name: Decreased hepatic GABA transaminase activity


name: Well-demarcated atrophy of central retina


name: Well-demarcated atrophy of pigment epithelium


name: Well-demarcated atrophy of choriocapillaris


name: Normal CSF 5-hydroxyindoleacetic acid (5-HIAA)


name: Impaired sensation in distal extremities, particularly pain and temperature (lower limbs more affected than upper limbs)


name: Sural nerve biopsy shows axonal neuropathy


name: AERODIGESTIVE TRACT CANCER, SUSCEPTIBILITY TO


name: Blistering, generalized, recurrent (occurs after mild physical trauma)


name: No clumping of keratin filaments in basal epidermal cells


name: Blistering, generalized, recurrent, severe (occurs after mild physical trauma)


name: Blistering occurs in clusters ('herpetiform', 'arcuate')


name: Blistering of hands, elbows, feet, knees


name: Postural dystonia (onset is restricted to 1 extremity, usually lower, with foot dystonia)


name: Decreased tetrahydrobiopterin (BH4) in CSF


name: Primary failure of tooth eruption (1st and 2nd molar teeth most commonly affected)


name: Expansion of helical fold at superior point of true longitudinal axis of ear


name: Megakaryocytes show large and irregular bleb protrusions


name: MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5


name: Demyelinating motor and sensory neuropathy


name: Individuals with normal NCV values have axonal CMT (CMT2M)


name: Seizures affect the vocal cords, lips, mouth, and face


name: Decreased conversion of beta-carotene to vitamin A (retinol)


name: Anemia, congenital hypoplastic, moderate-severe (normochromic, macrocytic)


name: Increased myeloid to erythroid ratio (M:E ratio) 10:1-200:1


name: Microbleeds (less than 5 mm in diameter) occur at the gray-white matter junction in the cerebral hemispheres and cerebellum and do not occur in the thalamus, basal ganglia, or brainstem


name: Liver biopsy during acute episode shows variable portal and sinusoidal fibrosis


name: Disturbed myelination affecting the periventricular and subcortical white matter


name: Brain MRS shows reduced choline and inositol peaks in the parieto-occipital white matter


name: Decreased CSF methyltetrahydrofolate (MTHF)


name: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1


name: LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1


name: LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO


name: LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO


name: LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO


name: Hypoplasia of anterior or entire pituitary gland (frequent)


name: Mental retardation (untreated hypothyroidism)


name: Open fontanelles (untreated hypothyroidism)


name: Low or absent thyroid-stimulating hormone (TSH)


name: HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO


name: Moderately decreased to normal PHK activity in skeletal muscle


name: FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1


name: Pigmented macular degeneration, adult-onset


name: HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA JAPONICUM INFECTION


name: Limited extension, flexion, pronation and/or supination of the forearm and/or hand


name: Shorter daily total sleep times compared to age-matched controls


name: Earlier sleep-offset time (earlier awakening)


name: Normal sleep-onset time (normal time of falling asleep)


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15


name: VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1


name: Markedly increased serum creatine kinase


name: Sparing of central white matter structures


name: Anterior temporal lobe subcortical cysts


name: Gray matter appears relatively unaffected


name: Generalized shortening of the long bones


name: Asymmetric shortening of long bones (radius, fibula, tibia)


name: Vertical creases of plantar surface between first and second toes


name: Uterine muscle may be stiff during pregnancy


name: Incomplete crista galli apophysis with small ethmoidal plate dehiscence


name: Hypoplastic and slightly abnormal odontoid process


name: Partial synostosis between the atlas and the base of the occiput


name: Cleft of cervical and dorsal vertebral bodies


name: MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4


name: MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3


name: MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2


name: MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3


name: MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2


name: Narcotic Cough/Cold Preparations Oral syrup


name: mesenchymal cell migration involved in limb bud formation


name: regulation of skeletal muscle tissue regeneration


name: inhibition of neuroepithelial cell differentiation


name: thyroid hormone receptor signaling pathway


name: regulation of skeletal muscle tissue development


name: production of molecular mediator involved in acute inflammatory response


name: vibrational conductance of sound to the inner ear


name: positive regulation of sperm motility involved in capacitation


name: positive regulation of epithelial cell proliferation involved in lung morphogenesis


name: smoothened signaling pathway involved in lung development


name: multicellular organismal-level iron ion homeostasis


name: fibroblast growth factor receptor signaling pathway involved in mammary gland specification


name: positive regulation of mammary placode formation by mesenchymal-epithelial signaling


name: positive regulation of lactation by mesenchymal-epithelial cell signaling


name: regulation of epithelial cell proliferation involved in mammary gland bud elongation


name: negative regulation of prostatic bud formation


name: regulation of branching involved in prostate gland morphogenesis


name: regulation of morphogenesis of a branching structure


name: regulation of branching involved in salivary gland morphogenesis


name: regulation of response to cytokine stimulus


name: positive regulation of response to cytokine stimulus


name: negative regulation of response to cytokine stimulus


name: regulation of branching involved in mammary gland duct morphogenesis


name: mesenchymal smoothened signaling pathway involved in prostate gland development


name: positive regulation of posterior neural plate formation by fibroblast growth factor receptor signaling pathway


name: smoothened signaling pathway involved in dorsal/ventral neural tube patterning


name: Notch signaling pathway involved in arterial endothelial cell fate commitment


name: positive regulation of floral organ abscission


name: negative regulation of floral organ abscission


name: regulation of floral organ abscission by signal transduction


name: positive regulation of cartilage development


name: negative regulation of cartilage development


name: negative regulation of vascular wound healing


name: regulation of branching involved in lung morphogenesis


name: positive regulation of branching involved in lung morphogenesis


name: negative regulation of branching involved in lung morphogenesis


name: peptidoglycan recognition protein signaling pathway


name: regulation of peptidoglycan recognition protein signaling pathway


name: positive regulation of peptidoglycan recognition protein signaling pathway


name: negative regulation of peptidoglycan recognition protein signaling pathway


name: regulation of nematode larval development


name: positive regulation of nematode larval development


name: negative regulation of nematode larval development


name: positive regulation of dauer larval development


name: negative regulation of dauer larval development


name: positive regulation of neural retina development


name: negative regulation of neural retina development


name: regulation of neuron projection regeneration


name: negative regulation of neuron projection regeneration


name: positive regulation of neuron projection regeneration


name: respiratory burst involved in defense response


name: immune response-regulating signaling pathway


name: Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation


name: smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation


name: Wnt signaling pathway involved in heart development


name: regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis


name: regulation of growth plate cartilage chondrocyte proliferation


name: growth plate cartilage axis specification


name: negative regulation of conidiophore stalk development


name: positive regulation of conidiophore stalk development


name: hydrogen peroxide mediated signaling pathway


name: organism emergence from protective structure


name: regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis


name: negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis


name: positive regulation of ureteric bud formation


name: positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis


name: negative regulation of response to water deprivation


name: positive regulation of leaflet formation by auxin mediated signaling pathway


name: positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway


name: regulation of establishment of planar polarity


name: regulation of pancreatic juice secretion


name: positive regulation of glomerulus development


name: negative regulation of glomerulus development


name: regulation of radial pattern specification


name: fibroblast growth factor receptor signaling pathway involved in somitogenesis


name: Wnt signaling pathway involved in somitogenesis


name: signal transduction involved in regulation of gene expression


name: BD Support Plus Hose P5 Beige Extra Tall


name: Thyroxine Sodium Pentahydrate, compounding powder


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND50140


name: TUBING,EXTENSION 15IN W/CONNECTOR RUSCH#A3605S


name: CATHETER,SUCTION 14-16FR W/VENT BARD #0109150


name: {180 (acamprosate calcium 333 MG Delayed Release Oral Tablet [Campral]) } Pack [Campral Dose Pak]


name: bioflavonoids-zinc glycinate 250 mg-50 mg oral capsule


name: bioflavonoids-zinc glycinate 500 mg-50 mg oral capsule


name: Homosalate/Octinoxate/Octisalate/Titanium Dioxide 5%-7.5%-5%-2.3% Topical application Lotion


name: blood-glucose meter and wrist blood pressure monitor MISCELL EACH


name: extracellular matrix, ovine derived, perforated


name: extracellular matrix (ECM), ovine derived


name: nutritional therapy, metabolic dis., mv, min no.5


name: nutritional therapy metabolic disorder,regular 160 kcal/42 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy, ketogenic, milk based with soy 3.09 gram-150 kcal/100 mL ORAL LIQUID (ML)


name: aloe vera/lactic acid/ceramides no.3/silicones/adhesive tape 1 %-1.6" X 4.8" TOPICAL KIT


name: {1 (acetaminophen 33.3 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution) / 1 (acetaminophen 33.3 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution) } Pack


name: pediatric nutrition, soy with iron, lactose free


name: pediatric nutrition, milk based, with iron


name: pediatric nutrition with iron, lactose free 2 gram-80 kcal/17 gram ORAL POWDER (GRAM)


name: pediatric nutrition,soy,iron,lactose-free 2 gram-80 kcal/17.5 gram ORAL POWDER (GRAM)


name: pediatric nutrition, milk based, with iron 2 gram-80 kcal/17 gram ORAL POWDER (GRAM)


name: Ointment with Applicator Drug Delivery System


name: Frozen Premix Intravenous Piggyback Solution Dosage Form


name: Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine


name: Date of myocardial infarction:Date:Pt:^Patient:Qn


name: Family history of sudden cardiac death (situation)


name: Stress Cardiac Magnetic Resonance Imaging


name: Pre-Test Probability of Coronary Artery Disease


name: Left Ventricle Size, End-Diastole, Quantitative


name: Left Ventricle Size, End-Systole, Quantitative


name: Coronary Artery Number of Diseased Vessels (Excludes Left Main Disease)


name: Proximal Left Anterior Descending Coronary Artery Stenosis


name: Left Main Coronary Artery Stenosis, Percentage


name: Proximal Left Anterior Descending Coronary Artery Stenosis, Percentage


name: Cytokeratin 5/6 Immunohistochemical Expression


name: Synaptophysin-Positive Neoplastic Cells Present


name: Last Observation Carried Forward Imputation Technique


name: Worst Observation Carried Forward Imputation Technique


name: Screening Observation Carried Forward Imputation Technique


name: Baseline Observation Carried Forward Imputation Technique


name: Mean of Other Group Imputation Technique


name: Penultimate Observation Carried Forward Imputation Technique


name: Worst Observed Value in a Group Imputation Technique


name: Mean Observed Value in a Group Imputation Technique


name: CDISC ADaM Date Imputation Flag Terminology


name: CDISC ADaM Time Imputation Flag Terminology


name: Brazelton Neonatal Behavioral Assessment Scale


name: Elevated Serum CA 27-29 Tumor Antigen Levels


name: Cytokeratin-Positive Neoplastic Cells Present


name: Third National Health and Nutrition Examination Survey


name: Reg upon Act Normal T-cell Exprd Secrtd Measurement


name: Mid-Molecule Parathyroid Hormone Measurement


name: N-Terminal Parathyroid Hormone Measurement


name: Anti-Saccharomyces cerevisiae Antibody Measurement


name: Aspartate Aminotransferase Antigen Measurement


name: Islet Neogenesis Associated Protein Antibody Measurement


name: Plasminogen Activator Inhibitor-1 Antigen Measurement


name: Thyroid Antithyroglobulin Antibody Measurement


name: Tissue Plasminogen Activator Antigen Measurement


name: Brain-Derived Neurotrophic Factor Measurement


name: Epithelial Neutrophil-Activating Peptide 78 measurement


name: Extracell Newly Ident RAGE Bind Protein measurement


name: Fatty Acid Binding Protein 1 Measurement


name: Fibroblast Growth Factor Basic Form Measurement


name: Glutamic Acid Decarboxylase 1 Measurement


name: Glutamic Acid Decarboxylase 2 Measurement


name: Glutamic Acid Decarboxylase 2 Antibody Measurement


name: Granulocyte Colony Stimulating Factor Measurement


name: Granulocyte Macrophage Colony Stimulating Factor Measurement


name: Macrophage Inflammatory Protein 1 Alpha measurement


name: Macrophage Inflammatory Protein 1 Beta measurement


name: Monocyte Chemotactic Protein 1 Measurement


name: Polymorphonuclear Neutrophil Elastase Measurement


name: Polymorphonuclear Pancreatic Elastase Measurement


name: Plasminogen Activator Inhibitor-1 Measurement


name: ProB-Type Natriuretic Peptide Measurement


name: Procollagen Type I Carboxy Terminal Peptide Measurement


name: Tissue Inhibitor of Metalloproteinase 1 Measurement


name: Type I Collagen C-Telopeptide Measurement


name: Type I Collagen N-Telopeptide Measurement


name: Type II Collagen C-Telopeptide Measurement